Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT00448760
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of adenocarcinoma of the esophagus meeting the following criteria:
* Stage II or III disease
* Resectable disease
* Previously untreated disease
* No stage I (mucosal only) or stage IV (metastatic) disease
PATIENT CHARACTERISTICS:
* WBC \> 3,000/mm\^3
* Absolute neutrophil count \> 1,500/mm\^3
* Platelet count \> 100,000/mm\^3
* Creatinine ≤ 2.0 mg/dL
* Bilirubin \< 2 times normal
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* Must have central venous access
* No other malignancy within the past 5 years
* No concurrent medical or psychiatric problem that would preclude study treatment
* No contraindications to paclitaxel
PRIOR CONCURRENT THERAPY:
* No prior chemotherapy or radiotherapy to the esophagus
* No oral cryotherapy (e.g., ice chips) on day 1 of each course
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
120 Years
Study:
NCT00448760
Study Brief:
Protocol Section:
NCT00448760